Search
for
Sort by
Research 31–60 of 65
- A Unique Case of Pili Multigemini Complicated by Folliculitis: Unveiling the Intricacies of a Rare Hair-Follicle Disorder
- Successfully Nonsurgical Epidermoid Cyst Management with Recombinant Hydrolytic Enzymes: A Case Report
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Microneedle Arrays Combined with Nanomedicine Approaches for Transdermal Delivery of Therapeutics
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Topical delivery of nanoemulsions for skin cancer treatment
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
- Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Autophagy: Guardian of Skin Barrier
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Cancer-Related Alopecia: From Etiologies to Global Management
- Proteomics as a tool to improve novel insights into skin diseases: what we know and where we should be going
- Diagnosis and Management of Melanoma of the Scalp: A Review of the Literature
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Beyond the Follicle: A Narrative Review on How Systemic Diseases and Drugs Affect Alopecia
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies